Buy Eris Lifesciences, target price Rs 1100: Prabhudas Lilladher

Eris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.

ETMarkets.com
Promoters held 54.9 per cent stake in the company as of 31-Mar-2024, while FIIs owned 14.27 per cent, DIIs 15.62 per cent.
Prabhudas Lilladher has buy call on Eris Lifesciences with a target price of Rs 1100. The current market price of Eris Lifesciences Ltd. is Rs 901.6.

Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 12347.29 Crore) operating in Pharmaceuticals sector.

Eris Lifesciences Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2023.



Financials
For the quarter ended 31-03-2024, the company reported a Consolidated Total Income of Rs 566.07 Crore, up 15.41 % from last quarter Total Income of Rs 490.49 Crore and up 40.19 % from last year same quarter Total Income of Rs 403.80 Crore. Company reported net profit after tax of Rs 79.63 Crore in latest quarter.


ADVERTISEMENT
Promoter/FII Holdings
Promoters held 54.9 per cent stake in the company as of 31-Mar-2024, while FIIs owned 14.27 per cent, DIIs 15.62 per cent.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Eris Lifesciences, target price Rs 1100: Prabhudas Lilladher
Text Size:AAA
Success
This article has been saved

*

+